Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. The study, led by the University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics , found anxiety was among the top three reasons for a medicinal cannabis prescription. The authors note, however, that the data doesn’t include patient outcomes. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Veriheal

MAY 3, 2022

The study was conducted by more than 10 researchers, with leads Dr. Jodi Gilman and Dr. Kevin Potter taking responsibility for the integrity and accuracy of the data. The team focused its efforts on understanding whether owning an MMJ card impacted CUD, particularly in terms of chronic pain, insomnia, anxiety, or depressive symptoms.

Research and Development 95

Research and Development Clinical Trials Consumption Patients 95

Canna Care Docs

DECEMBER 16, 2020

Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). Chronic pain. One of the most widespread uses of medical marijuana is for chronic pain. What is medical marijuana?

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Puff Puff Post

JANUARY 1, 2020

Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronic pain.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

Puff Puff Post

JANUARY 1, 2020

Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Early studies suggest, and patients confirm, the use of cannabis i n pain management for cancer. With increasing social acceptance more doctors feel comfortable recommending it to treat chronic pain.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Weedistry

JANUARY 28, 2019

Cannabinoid-derived product by Ontario-based Tetra Bio-Pharma to be officially recognized as a drug. The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. Something needs to be done”: Making medicine attainable and affordable.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

The Herb Collective

JUNE 3, 2018

Treats Chronic Pain Patients suffering from chronic pain have reported that CBD oil acts as a soothing agent. The product also stabilizes blood sugar levels, prevents inflammation in nerves, relieves muscle cramps and gastrointestinal pains, lowers blood pressure, helps diabetics with restless leg syndrome (RLS).

Oil 56

Oil CBD Blood Pressure Chronic Pain 56

Veriheal

AUGUST 31, 2020

Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

The Joint Blog

APRIL 17, 2020

Over the past few decades, there has been an increased interest in leveraging cannabis and cannabinoids for medicinal purpose. Crohn’s ), chronic pain , appetite loss , issues with sleep , immune system disorders , thermoregulation problems, cancer and more.

Events 48

Events THC Chronic Pain Sleep 48

CannaTech

SEPTEMBER 16, 2018

But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression. This knowledge gap isn’t surprising, as cannabis as a medicine is non-traditional in its very nature.

Education 66

Education Medicine Clinical Trials Patients 66

Veriheal

JANUARY 5, 2023

A separate report published by Data Bridge Market research spotlighted the sheer size of the CBD market. The cannabinoid is being utilized for a broad spectrum of medical problems, such as chronic pain, stress, anxiety, sleep/insomnia, skin care, migraine, seizures, neurological conditions, and inflammation.

Clinical Trials 82

Clinical Trials Safety Consumption CBD 82

Project CBD

FEBRUARY 27, 2023

But there’s another option that can address mood, pain, and more at once, all with fewer side effects: cannabis. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” It’s not a new idea.

THC 144

THC CBD Sleep Clinical Trials 144

Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

The Cannigma

JANUARY 13, 2023

A review of existing endocannabinoid system and migraine research from March 2022 identified many surveys, but fewer clinical research trials, and even fewer double-blind placebo studies. 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines.

Terpenes 132

Terpenes Strains THC Treatment 132

The Cannigma

APRIL 8, 2021

Yeah, there are thousands of strains, but those thousands of strains, but those thousands of strains only make let’s say one or two of 60 cannabinoids in abundance. Half of those cannabinoids of plant doesn’t make or three quarters because they’re byproducts. This is by nature of the way we consume cannabinoids.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

The Cannigma

FEBRUARY 11, 2021

Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Cannabis Law Report

MAY 13, 2019

“There’s still a lot we don’t know about medicinal cannabis … when it comes to the pharmacology, what does it do on a molecular level and how does it affect things like chronic pain or symptoms of MS [multiple sclerosis]?”. Data Availability: All relevant data are within the paper and its Supporting Information files.

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Puff Puff Post

SEPTEMBER 16, 2019

This new initiative developed by Santé Cannabis equips physicians with the most up-to-date clinical guidelines, support networks, online and in-person training opportunities so they can prescribe and monitor cannabinoid treatment plans with confidence. Clinical toolkits to help navigate patient assessment and follow-ups.

Programs 108

Programs Research and Development Education Treatment 108

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Data collection. 2016 ; Sznitman et al. years (Atakan 2012 ).

Research and Development 52

Research and Development Medicine Access Media 52

Puff Puff Post

SEPTEMBER 16, 2019

This new initiative developed by Santé Cannabis equips physicians with the most up-to-date clinical guidelines, support networks, online and in-person training opportunities so they can prescribe and monitor cannabinoid treatment plans with confidence. Clinical toolkits to help navigate patient assessment and follow-ups.

Programs 40

Programs Research and Development Education Treatment 40

Cannabis Law Report

OCTOBER 17, 2019

THC is just one of the cannabinoids in the Cannabis sativa L. The other major cannabinoid of particular interest commercially is cannabidiol (CBD). All told, the global legal cannabis industry, including dried cannabis and products containing cannabinoids, was estimated at US $11.9

Law 40

Law Seed-To-Sale Hemp Recreational 40